Synpromics is developing a strategic portfolio of valuable synthetic promoters for specific application across its target markets, such as cell & gene therapy, bio-manufacturing and industrial & agricultural biotechnologies.
Synpromics is developing a strategic portfolio of valuable synthetic promoters for specific application across its target markets, such as cell & gene therapy, bio-manufacturing and industrial & agricultural biotechnologies.
Location:
Roslin Innovation Centre, Easter Bush Campus, Midlothian, EH25 9RG
Categories:
The Synthetic Genome, Synthetic Cells Tissues and Beyond
Founded in:
2010
Employee number:
10-100
Annual revenue:
$5M